ATHOS BIOINDUSTRIES
Athos Bioindustries is an industrial biotech company that harness microbial consortia from mining waste into minerals.
ATHOS BIOINDUSTRIES
Social Links:
Industry:
Biotechnology Chemical Manufacturing
Founded:
2024-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.athos.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Algasol
Algasol is a biotechnology company that provides algae biomass products for cosmetics, pharmaceutical, plastics, and biofuel industries.
BioLogic Company
BioLogic Company is a biotechnology company that manufactures and supplies natural pest control products.
Kalion
Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.
Nature Plus
NPI is a biotechnology company that manufactures specialty formulations for industrial and consumer applications.
Polestar Technologies
Polestar Technologies is a biotechnology company that offers optical monitoring and sensor products for industrial & commercial industries.
Tex Biosciences
Tex Biosciences is an industrial biotech company that manufactures enzymes, probiotics, and other biotech products.
Toyobo USA
Toyobo USA is a chemical company that provides functional polymers, industrial materials, and healthcare products.
Investors List
Official Site Inspections
http://www.athos.bio
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "Athos Bioindustries"
Athos - IndieBio - #1 in Early Stage Biotech
Athos Bio is developing bio-mineralization technology that mitigates this waste, transforming it into a medium for permanent carbon storage and the recovery โฆSee details»
Athos Bioindustries - Crunchbase Company Profile
When was the last funding round for Athos Bioindustries? Athos Bioindustries โฆSee details»
Athos Bioindustries 2025 Company Profile: Valuation, โฆ
Athos Bioindustries General Information Description. Developer of bio โฆSee details»
Athos Therapeutics Inc. - BIO International Convention 2025
Athos is a clinical stage biotech pioneering the development of Artificial Intelligence-based, first-in-class precision therapeutics for patients with IBD (entering a Phase 2 in UC with ATH-063), โฆSee details»
All Three Athos Co-Founders Named to Stanfordโs List of the โฆ
Oct 12, 2023 "It is a great honor to be included together with all the Athos co-founders in Stanford's prestigious list of the world's top 2% of scientists," said Dimitrios Iliopoulos, PhD, โฆSee details»
Home - Athos Therapeutics
Athos Therapeutics Innovative Drug Discovery & Development Platform. Athos has developed a unique platform able to identify and develop novel drugs for โฆSee details»
Athos - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 27, 2025 Athos - Provider of solution to turn mining waste into industrial materials. Raised funding from 1 investor. Founded by Liz Muntean, Matthew LaRosa and 1 other in the year โฆSee details»
Athos - SOSV
Athos.bio . Team Gabriel Villar. CEO. Matthew La Rosa. Chief Technology Officer ... Get In Touch with Athos. Please tell us a little bit about yourself and why โฆSee details»
Athos - Products, Competitors, Financials, Employees, โฆ
Athos was founded in 2024. Where is Athos's headquarters? Athos's headquarters is located at 7 Penn Plaza, New York. What is Athos's latest funding round? Athos's latest funding round is โฆSee details»
Athos Bioindustries, Inc. - Drug pipelines, Patents, Clinical trials ...
Dec 11, 2024 Last update 02 Nov 2024. Athos Bioindustries, Inc. Private Company |See details»
Athos, an autoimmune and cancer biotech, is raising โฆ
Feb 16, 2024 Athos Therapeutics is raising ... field has experienced a rush of activity in the past year with big-name deals like Merckโs Prometheus โฆSee details»
Athos Service GmbH - life-sciences-usa.com
BIO-Europe 2025 Vienna (Wien) BIO-Europe Spring 2026 Lisboa (Lisbon) ... BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) France โฆSee details»
A Co-Founder of Athos Therapeutics, Dr. Michael E. Jung
May 1, 2025 LOS ANGELES, CA / ACCESS Newswire / April 30, 2025 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision โฆSee details»
All Three Athos Co-Founders Named to Stanfordโs ... - Athos โฆ
Oct 12, 2023 The complementary expertise of the Athos co-founders has been a key factor in Athosโs rapid development of its lead program (ATH-063) from concept to phase I clinical trial โฆSee details»
Athos, an autoimmune and cancer biotech, is raising $35M for โฆ
Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small โฆSee details»
athosliving.com Reviews: Is this site a scam or legit?
Is athosliving.com legit? It's definitely questionable. If you plan to do business on this site, proceed with caution as it received a medium score on our chart. We put to work 53 powerful โฆSee details»
BIO Announces Dedicated Focus on Human Health and โฆ
1 day ago Washington, DC, May 28, 2025 โ The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work โฆSee details»
Media - Athos Therapeutics
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory โฆSee details»
ATH-293 - Drug Targets, Indications, Patents - Synapse
ATH-293, Initially developed by Athos Therapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Congenital ...See details»
Athos, an autoimmune and cancer biotech, is raising $35M for โฆ
Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small โฆSee details»